Entrectinib/larotrectinib/selitrectinibAcquired drug resistance: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1780卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71640-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：149 / 149

相关论文

共 50 条

[41] LinezolidEmergence of drug resistance: 8 case reports
Reactions Weekly, 2020, 1785 (1) : 316 - 316
[42] AntineoplasticsAcquired drug resistance: 2 case reports
Reactions Weekly, 2023, 1950 (1) : 42 - 42
[43] LinezolidAcquired drug resistance: 13 case reports
Reactions Weekly, 2020, 1822 (1) : 187 - 187
[44] AntitubercularsAcquired drug resistance: 4 case reports
Reactions Weekly, 2022, 1937 (1) : 83 - 83
[45] AntiretroviralsAcquired drug resistance: 8 case reports
Reactions Weekly, 2021, 1855 (1) : 57 - 57
[46] OsimertinibAcquired drug resistance: 4 case reports
Reactions Weekly, 2022, 1911 (1) : 340 - 340
[47] AfatinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2019, 1749 (1) : 22 - 22
[48] OsimertinibAcquired drug resistance: 22 case reports
Reactions Weekly, 2020, 1829 (1) : 304 - 304
[49] GanciclovirDevelopment of drug resistance : 2 case reports
Reactions Weekly, 2022, 1900 (1) : 152 - 152
[50] AntineoplasticsAcquired drug resistance: 5 case reports
Reactions Weekly, 2022, 1910 (1) : 53 - 53

← 1 2 3 4 5 →